Cytometry Part B: Clinical Cytometry
© The International Clinical Cytometry Society
Edited By: Frederic I. Preffer
Impact Factor: 2.822
ISI Journal Citation Reports © Ranking: 2015: 6/30 (Medical Laboratory Technology); 21/78 (Pathology)
Online ISSN: 1552-4957
Associated Title(s): Cytometry Part A
Introducing Accepted Articles publication for Cytometry Part B: Clinical Cytometry
Papers accepted for publication in Cytometry Part B will now publish online as Accepted Articles within 5-7 days after acceptance and indexed by PubMed within 48 hours of release into the public domain. The paper will be published in its final format in print and this version will also replace the Accepted Article (unedited) version online. Please note that Accepted Article publication makes it incumbent upon the authors to submit their revisions with little or no alterations necessary.
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement
For additional tools visit Author Resources - an enhanced suite of online tools for Wiley InterScience journal authors, featuring Article Tracking, E-mail Publication Alerts and Customized Research Tools..
Manuscripts should be submitted online at http://mc.manuscriptcentral.com/cytometry/cc . Authors are encouraged to provide the names and addresses of possible reviewers outside their own institutions.
Conflict of Interest Disclosure
Cytometry Part B: Clinical Cytometry requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, that might be perceived as influencing an author’s objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or indirectly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include but are not limited to patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker’s fees from a company. The existence of a conflict of interest does not preclude publication in this journal.
If the authors have no conflict of interest to declare, they must also state this at submission.It is the responsibility of the corresponding author to review this policy with all authors and to collectively list in the cover letter to the Editor-in-Chief, in the manuscript (under the Acknowledgments section), and in the online submission system ALL pertinent commercial and other relationships.
To ensure rapid and accurate publication, it is essential that the manuscript conform to the following instructions. Manuscripts that are not in accordance with these specifications may be returned to the author.
Manuscripts will appear under one of the following sections: Original Article, Review Article, Controversies in Clinical Cytometry, Brief Communication, or Regional Spotlight.
In all cases the manuscript should be consistent with style, spellings and use of abbreviations. Authors in Japan please note: Wiley-Japan can provide authors in Japan with a list of recommended services to check and improve the English in their papers BEFORE SUBMISSION. Japanese authors can find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html. We recommend that the manuscript be typed double-spaced with a 1 1/2" margin on all sides. Number the manuscript pages consecutively beginning with the title page. Hyphenation and justification should not be used. The manuscript should not exceed 8-12 double-spaced typewritten pages (including references, figures, and tables). If you wish to propose a manuscript size and page margin format outside of these requirements, you can do so by including a request in your cover letter which will then be considered by the Editor-in-Chief. Manuscripts should contain each of the following elements in sequence:
1. Title Page
7. Figure Legends
Define unusual abbreviations at the first mention in the text. Abbreviate measurements according to the Council of Biology Editors Style Manual (CBE Style Manual), fifth edition, available from the Council of Biology Editors, Inc., 11 South LaSalle Street, Chicago, IL 60603-1210. Enzyme names and units must follow the recommendations of The Nomenclature Committee of the International Union of Biochemistry. Webster's Third International Dictionary is the accepted source for spelling and capitalization. The units for all measurements must conform to the International System of Units (SI). If a measurement is made in other units, then the SI equivalent should be given in parentheses. If authors refer to specific products of companies, they must identify the company by citing, in parentheses, its name, city, and state or country.
Title Page. The title page should contain the following information: Complete title of the manuscript; a running title (not to exceed 54 characters and spaces); the names, titles, and affiliations of all authors (specific to the department level); the name, complete address, and telephone, FAX and electronic mailbox numbers of the corresponding author; three to five key words that will highlight the subject matter of the article.
Abstract. Authors are required to provide a structured abstract. The abstract, which should not exceed 250 words, should consist of four paragraphs, labeled: Background, Methods, Results, Conclusions. They should describe, respectively, the reason for the study, how the study was performed, the most important results, and what is concluded from the results. The subject under investigation and technologies or methods employed must be included. The Medical Subject Headings List from Index Medicus should be used whenever possible.
Manuscripts containing original work addressing the practice of clinical cytometry and the underlying methodology. Both flow or image cytometry are appropriate. This includes reports of clinical trials, diagnostic applications of flow and image cytometry and case series reports as well as new advances in instrumentation, methods, reagents, and data analysis techniques. Clinical research manuscripts including the transition of new, and novel, cytometry techniques to clinical testing are welcome. Consensus and guideline documents relating to clinical cytometry are of high interest to the Journal and are welcome under this category.
Review articles which comprehensively summarize, and review, the current state, and future directions, of clinical cytometry testing and the underlying instrumentation and procedures relating to the application of flow and image cytometry to clinical diagnosis and patient management.
Controversies in Clinical Cytometry:
Forum for the presentation, and discussion, of controversial areas in clinical cytometry. The presentation of multiple viewpoints encompassing all sides of an issue are encouraged including contributions from one or more authors in the same submission. One of the goals of this section is to promote discussion and thought in areas of controversy or where consensus development is needed. Also welcome are discussions of questions, or concerns, relating to the daily practice of clinical cytometry. This includes standards for quality control/quality assurance, safety issues, laboratory management, professional considerations, and results reporting. These contributions are intended to be short, opinion pieces which in general are invited. However, un-solicited submissions will be considered and suggestions of topics, or areas of controversy, to the Editor, Deputy Editor, or Associate Editors are encouraged.
Cytometry Brief Contributions:
Letters to the Editor addressing issues raised in Cytometry Part B: Clinical Cytometry or other matters of general interest to clinical cytometry practitioners. Single Case Reports are also invited within this section. Brief Observations and Rapid Communications which are not broad enough in scope to be an Original article will also be considered. Contributions in all areas within the scope of the journal will be considered, however, the material must be adequately presented in less than three journal pages and contain at most one Figure and one Table.
Forum for cytometry related national and regional societies/organizations to present items of interest to the world wide clinical cytometry community. The major focus of this section is to provide a vehicle for smaller, developing societies and organizations to more effectively voice issues and points of view to the broader cytometry community.
References to published literature should be cited in the text numerically with the reference number entered in parentheses. If an author's name is used in the text, the reference number must follow the name at an appropriate point in the same sentence.
References must only be made to published papers and papers in press. Work in progress, unpublished experiments, and personal communications are specifically excluded from the reference list but may be acknowledged in parentheses in the text. References must be numbered serially and arranged alphabetically by the last name of the first author, by coauthors, and chronologically by the same author. Abbreviations of journal names must conform to those used in Index Medicus . Authors are responsible for the accuracy of references. The following formats must be used for references:
1. Brando B, Sommaruga E. Nationwide quality control trial on lymphocyte phenotyping and flow cytometry performance in Italy. Cytometry 1993;14:294-306.
Article in a book or comparable publication.
2. Gray JW, Cram LS. Flow karyotyping and chromosome sorting. In: Melamed MR, Lindmo T, Mendelsohn ML, editors. Flow cytometry and sorting. 2nd ed. New York: John Wiley & Sons, Inc.; 1990. p 503-529.
3. Givan AL. Flow cytometry: first principles. New York: John Wiley & Sons, Inc.; 1992. 1223 p.
Tables. Each table must have a title and should be self-explanatory. Avoid duplicating information in the text. Number tables with Arabic numerals in order of appearance in the text.
Rapid Inspector TM gives authors of scientific, technical, and medical journals a resource for certifying their illustrations prior to submission. Utilizing this software will ensure that your graphics are suitable for print production. To download this journal's free Rapid Inspector software, please visit http://rapidinspector.cadmus.com/RapidInspector/zwi/index.jsp .
Authors are encouraged to visit http://cpc.cadmus.com/da/ for supported artwork formats.
All color figures will be reproduced in full color in the online edition of the journal at no cost to authors. Authors are requested to pay a charge of $500.00 per page to reproduce color figures in print. Authors are encouraged to submit color illustrations that highlight the text and convey essential scientific information. For best reproduction, bright, clear colors should be used. Dark colors against a dark background do not reproduce well; please place your color images against a white background wherever possible. Please contact Larry Graup at firstname.lastname@example.org for further information. One or, exceptionally, more pages of color will be considered for print publication at no cost to the authors, subject to editorial recommendation.
Reprints may be purchased at https://caesar.sheridan.com/reprints/redir.php?pub=10089&acro=cytob
Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate .